King Pharmaceuticals®, Inc. Unit, Alpharma Inc. to Pay $42.5 Million Over Kadian Claims

Published: Mar 17, 2010

Reuters -- Alpharma Inc, a unit of King Pharmaceuticals (KG.N), has agreed to pay $42.5 million to resolve allegations that it gave kickbacks to doctors to prescribe the pain drug Kadian and misrepresented its safety and effectiveness, the Justice Department said on Tuesday.

Back to news